20525 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
Compositions and kits for treating influenza
#1202Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
#1203Nutrient compositions and methods for enhanced effectiveness of the immune system
#1204METHOD FOR TREATING HEPATITIS C VIRUS INFECTION IN TREATMENT FAILURE PATIENTS
#1205FLAVIN N-OXIDES: NEW ANTI-CANCER AGENTS AND PATHOGEN ERADICATION AGENTS
#1206Diagnosis and Treatment of Diseases Arising from Defects in the Tuberous Sclerosis Pathway
#1207Use of compounds that are able to increase the serum IGF-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced IGF-1 serum level in humans and animals
#1208Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
#1209IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO HCV-796, AND METHODS RELATED THERETO
#1210Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
#1211Compounds that interact with kinases
#1212Treating hepatitis C virus infection
#1213DRUG DELIVERY POLYMER WITH HYDROCHLORIDE SALT OF CLINDAMYCIN
#12141(Beta-D-Glycopyranosyl)-3-Substituted Nitrogenous Heterocyclic Compound, Medicinal Composition Containing the Same, and Medicinal Use Thereof
#1215COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONS
#1216Hyaluronate compositions
#1217Indolopyrrolocarbazole derivatives and anti-tumor agent
#1218Inhibitors of Hepatitis C Virus
#1219Crystalline forms of an antiviral benzimidazole compound
#1220Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents
#1221Medicinal composition containing diabetes remedy
#1222ANTIBIOTIC COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT
#1223Combination of FBPase Inhibitors and Insulin Sensitizers for the Treatment of Diabetes
#1224COMPOSITIONS AND THERAPEUTIC METHODS OF USE
#1225Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
#1226Pyrazole derivatives and diabetic medicine containing them
#1227Methods and Compositions for the Prevention and Treatment of Inflammatory Diseases or Conditions
#1228Foamable suspension gel
#1229Combination therapy for anthrax using antibiotics and protease inhibitors
#1230Dimeric compounds and their use as anti-viral agents
#1231Dimeric compounds and their use as anti-viral agents
#1232Dimeric compounds and their use as anti-viral agents
#1233Novel HCV inhibitor combinations and methods
#1234COMPOSITONS AND METHODS OF USE OF RITONAVIR FOR TREATING HCV
#1235Method Of Treating Viral Infections
#1236Soft tissue implants and drug combination compositions, and use thereof
#1237Method of treating hepatitis C infection
#1238Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
#1239Animal feed composition
#1240Oral ribavirin pharmaceutical compositions
#1241Oral ribavirin pharmaceutical compositions
#1242POLYCYCLIC PHENOLIC COMPOUNDS AND USE IN TREATING VIRAL INFECTIONS
#1243LARGE DOSE RIBAVIRIN FORMULATIONS
#1244USE OF BVDU FOR INHIBITING THE GROWTH OF HYPERPROLIFERATIVE CELLS
#1245Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
#1246Hmpv treatment with ribavirin and anti-hmpv antibody
#1247Remedy for sarcoidosis and method of treating the same
#1248Inhibiting GS-FDH to modulate no bioactivity
#1249Pyrazole derivatives and diabetic medicine containing them
#1250Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs
#1251Topical pharmaceutical composition for the treatment of inflammatory dermatoses
#1252Modified 2′ and 3′-nucleoside prodrugs for treating infections
#1253Formulations of AICA riboside
#1254Continuous delivery methods for treating hepatitis virus infection
#1255Methods for preventing and treating metabolic disorders and new pyrazole-O-glycoside derivatives
#1256Method of treating hepatitis B viral infection
#1257Composition and method for treating graft-versus-host disease
#1258Targeted delivery of antiviral compounds through hemoglobin bioconjugates
#1259Pyrazole derivative, drug composition containing the same and production intermediate therefor
#1260IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME
#1261Novel method of treatment of inflammatory skin conditions
#1262Modified 2′ and 3′-nucleoside prodrugs for treating infections
#1263Novel indolopyrrolocarbazole derivative with antitumor activity
#1264Modified 2′ and 3′-nucleoside prodrugs for treating infections
#1265Modified 2′ and 3′-nucleoside prodrugs for treating infections
#1266Methods and compositions for treating flaviviruses and pestiviruses
#1267Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
#1268Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
#1269Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#1270Inhibitors of nitric oxide synthase to treat type 1 diabetes
#1271Modified 2′ and 3′-nucleoside prodrugs for treating infections
#1272Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#1273Hepatitis C virus non-structural NS3/4A fusion gene
#1274Interferon beta in severe acute respiratory syndrome (sars)
#1275Antidepressants or foods and beverage for antidepression
#1276Modulation of endogenous AICAR levels for the treatment of diabetes and obesity
#1277Methods of treating gastrointestinal inflammation
#1278Methods, compositions, and formulations for preventing or reducing adverse effects in a patient
#1279Remedy or preventive for kidney disease and method of diagnosing kidney disease
#1280Indole compounds useful for the treatment of cancer
#1281PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PSORIASIS
#1282Interferon for treating or preventing a coronaviral infection
#1283Combined use of ribavirin and interferon beta in demyelinating diseases
#1284Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#1285Use of dronabinol for treatment of side effects of Hepatitis C therapy
#1286Plant seed extract composition and process for producing the same
#1287Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
#1288Multipathogen and monopathogen protection against the bacterial and viral infections associated with biological warfare, cardiac diseases, and cancers
#1289Methods and products related to treatment and prevention of hepatitis C virus infection
#1290Ring-expanded nucleosides and nucleotides
#1291Uses of neuraminidase inhibitors in infectious diseases
#1292Hepatitis C therapies
#1293Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#1294Compositions and methods for treating or preventing flaviviridae infections
#1295Vaccines containing ribavirin and methods of use thereof
#1296Inhibitors of HCV replication
#1297Methods and compositions for treating flaviviruses and pestiviruses
#1298Methods of treating disease with glycosylated interferon
#1299Inhibition of SARS coronavirus infection with clinically approved antiviral drugs
#1300Method for treating HIV infection through co-administration of tipranavir and GW695634
#1301Composition for topical treatment of mixed vaginal infections
#1302Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
#1303Dose forms
#1304Method to enhance delivery of glutathione and ATP levels in cells
#1305Glucopyranosyloxypyrazole derivatives and use thereof in medicines
#1306Compositions for controlled delivery of pharmaceutically active compounds
#1307Combination anti-viral compositions and methods of use
#1308Drug for reducing side effects in ribavirin interferon combination therapy
#1309Large dose ribavirin formulations
#1310Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol
#1311Methods for treating psychosis associated with interferson-α therapy
#1312Hepatitis C virus non-structural NS3/4A fusion gene
#1313Methods of treating proliferative skin diseases using carbazole derivatives
#1314Pyrazole derivatives and diabetic medicine containing them
#1315Glucopyranosyloxypyrazole derivatives and use thereof in medicines
#1316Preventive or remedy for diseases caused by hyperglycemia
#1317Composition and method for treating graft-versus-host disease
#1318Glucopyranosyloxypyrazole derivatives and use thereof in medicines
#1319Treatments for viral infections using IFN cytokines and ribavirin, alone or in combination
#1320Compositions and methods for preventing or treating encephalitis with interferon
#1321Method for treatment and prevention of herpes zoster by topical application
#1322Methods and products related to treatment and prevention of hepatitis C virus infection
#1323Combinations for HCV treatment
#1324Topical pharmaceutical composition to treat hyperpigmentation of the skin
#1325Prodrugs for phosphorus-containing compounds
#1326Enhanced compliance antiviral medicaments and methods of manufacture and use
#1327Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#1328Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
#1329Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives
#1330Flavin N-oxides: new anti-cancer agents and pathogen eradication agents
#1331Therapeutic use of riboside of 5-aminoimidazole-4-carboxamide (acadesine)
#1332Compounds that interact with kinases
#1333Method for identifying compounds or lead structures against rna target motifs and rna/protein interactions
#1334Methods of treating an inflammatory-related disease
#1335Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
#1336Combination of a Cox-2 inhibitor and a DNA topoisomerase I inhibitor for treatment of neoplasia
#1337Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitors
#1338Method of using protease inhibitors for the treatment of liposarcomas
#1339Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
#1340Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination
#1341Nucleoside analogs with carboxamidine modified monocyclic base
#1342Process for producing erythromycin a derivative
#1343Use of ribofuranose derivatives against inflammatory bowel diseases
#1344Use of ribofuranose derivatives against inflammatory bowel diseases
#1345Compositions and methods for the treatment of cancer
#1346Prophylactic and therapeutic agent of diabetes mellitus
#1347Nutrient compositions and methods for enhanced effectiveness of the immune system
#1348Methods and compositions for treating hepatitis C virus
#1349Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
#1350Methods and compositions for treating hepatitis C virus
#1351DAPD combination therapy with inosine monophosphate dehydrogenase inhibitor
#1352Combination therapy for HCV infection
#1353Down-regulation of DNA repair to enhance sensitivity to p53-mediated suppression
#1354Use of BVDU for inhibiting the growth of hyperproliferative cells
#1355Process for producing wet ribavirin pellets
#1356Transdermal and topical administration of drugs using basic permeation enhancers
#1357Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
#1358Targeted delivery of antiviral compounds through hemoglobin bioconjugates
#1359Dimeric compounds and their use as anti-viral agents
#1360Dimeric compounds and their use as anti-viral agents
#1361Dimeric compounds and their use as anti-viral agents
#1362Pyrazole derivatives and diabetic medicine containing them
#1363Method of treating hepatitis C infection
#1364Method for treating hepatitis c virus infection in treatment failure patients
#1365Method for treating hepatitis c virus infection in treatment failure patients
#1366Treatment of HIV infection through combined administration of tipranavir and capravirine
#1367Composition containing ribavirin and use thereof
#1368Use of ribofuranose derivatives against inflammatory bowel diseases
#1369Use of ribofuranose derivatives against inflammatory bowel diseases
#1370Use of ribofuranose derivatives against inflammatory bowel diseases
#1371Compositions and methods for treating coronavirus infection and SARS
#1372Methods and compositions using AMPK activators for pharmacological prevention of chronic pain